Strategic Partnerships HighRes has been actively forming alliances with Waters Corporation, Cenevo, and Opentrons in 2026 to advance drug discovery, AI-ready lab infrastructure, and AI agent-to-agent automation workflows, signaling a compelling opportunity to align with their partner ecosystem for co-sell or integrated solutions.

Robotics Automation As the leading global lab automation company, HighRes emphasizes connecting instrumentation, software, and data to boost scientist productivity, presenting a strong case for expanding conversations around end-to-end robotic automation, data integration, and scalable infrastructure for biotechn labs.

AI and Cloud Recent collaborations highlight a focus on AI-enabled workflows and connected lab infrastructure, complemented by a tech stack across AWS, Google Cloud, Azure, Terraform, Docker, and more, creating cross-sell opportunities for advanced analytics, AI agents, and secure cloud-based deployment.

Financial Footing With reported revenue in the tens of millions range, HighRes shows mid-market scale with room for growth through expanded automations and instrumentation integration, suggesting efficient deal sizing for mid- to high-value lab automation and software deployments.

Market Positioning Target peers and competitors include Brooks Automation and other major lab automation players, indicating a competitive opportunity to differentiate through integrated platforms, AI-ready workflows, and globally connected solutions that appeal to mid- to large-sized biotechnology labs seeking productivity gains.